Literature DB >> 28775051

Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research.

Tim Lahm1,2,3, Steven M Kawut4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28775051     DOI: 10.1183/13993003.00983-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  33 in total

1.  Sex-dependent influence of endogenous estrogen in pulmonary hypertension.

Authors:  Kirsty M Mair; Audrey F Wright; Nicholas Duggan; David J Rowlands; Martin J Hussey; Sonia Roberts; Josephine Fullerton; Margaret Nilsen; Lynn Loughlin; Matthew Thomas; Margaret R MacLean
Journal:  Am J Respir Crit Care Med       Date:  2014-08-15       Impact factor: 21.405

Review 2.  Estrogen signaling and cardiovascular disease.

Authors:  Elizabeth Murphy
Journal:  Circ Res       Date:  2011-09-02       Impact factor: 17.367

3.  Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury.

Authors:  Gary Pare; Andrée Krust; Richard H Karas; Sonia Dupont; Mark Aronovitz; Pierre Chambon; Michael E Mendelsohn
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

4.  Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.

Authors:  Aiping Liu; David Schreier; Lian Tian; Jens C Eickhoff; Zhijie Wang; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-06-06       Impact factor: 4.733

5.  Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle.

Authors:  Tim Lahm; Ketan M Patel; Paul R Crisostomo; Troy A Markel; Meijing Wang; Christine Herring; Daniel R Meldrum
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-06-26       Impact factor: 4.310

6.  Determinants of right ventricular ejection fraction in pulmonary arterial hypertension.

Authors:  Steven M Kawut; Nadine Al-Naamani; Cara Agerstrand; Erika Berman Rosenzweig; Cherise Rowan; Robyn J Barst; Steven Bergmann; Evelyn M Horn
Journal:  Chest       Date:  2008-10-10       Impact factor: 9.410

7.  17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension.

Authors:  Aiping Liu; Lian Tian; Mark Golob; Jens C Eickhoff; Madison Boston; Naomi C Chesler
Journal:  Hypertension       Date:  2015-09-21       Impact factor: 10.190

8.  Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function.

Authors:  Corey E Ventetuolo; Nandita Mitra; Fei Wan; Ani Manichaikul; R Graham Barr; Craig Johnson; David A Bluemke; Joao A C Lima; Hari Tandri; Pamela Ouyang; Steven M Kawut
Journal:  Eur Respir J       Date:  2015-12-02       Impact factor: 16.671

9.  Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Authors:  Karen M Olsson; Marion Delcroix; H Ardeschir Ghofrani; Henning Tiede; Doerte Huscher; Rudolf Speich; Ekkehard Grünig; Gerd Staehler; Stephan Rosenkranz; Michael Halank; Matthias Held; Tobias J Lange; Juergen Behr; Hans Klose; Martin Claussen; Ralf Ewert; Christian F Opitz; C Dario Vizza; Laura Scelsi; Anton Vonk-Noordegraaf; Harald Kaemmerer; J Simon R Gibbs; Gerry Coghlan; Joanna Pepke-Zaba; Uwe Schulz; Matthias Gorenflo; David Pittrow; Marius M Hoeper
Journal:  Circulation       Date:  2013-09-30       Impact factor: 29.690

10.  Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension.

Authors:  Kevin White; Anne Katrine Johansen; Margaret Nilsen; Loredana Ciuclan; Emma Wallace; Leigh Paton; Annabel Campbell; Ian Morecroft; Lynn Loughlin; John D McClure; Matthew Thomas; Kirsty M Mair; Margaret R MacLean
Journal:  Circulation       Date:  2012-08-02       Impact factor: 29.690

View more
  6 in total

1.  Insulin Resistance Is Associated with Right Ventricular Dysfunction.

Authors:  Jeff Min; Mary E Putt; Wei Yang; Nadine Al-Naamani; Alain G Bertoni; Joao A C Lima; R Graham Barr; Lauren Beussink-Nelson; Sanjiv J Shah; Steven M Kawut; Benjamin H Freed
Journal:  Ann Am Thorac Soc       Date:  2022-04

Review 2.  Pulmonary arterial hypertension: pathogenesis and clinical management.

Authors:  Thenappan Thenappan; Mark L Ormiston; John J Ryan; Stephen L Archer
Journal:  BMJ       Date:  2018-03-14

3.  Exogenous Estrogen Preserves Distal Pulmonary Arterial Mechanics and Prevents Pulmonary Hypertension in Rats.

Authors:  Jennifer L Philip; Diana M Tabima; Gregory D Wolf; Andrea L Frump; Tik-Chee Cheng; David A Schreier; Timothy A Hacker; Tim Lahm; Naomi C Chesler
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 30.528

Review 4.  Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.

Authors:  Tanvirul Hye; Pankaj Dwivedi; Wei Li; Tim Lahm; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-10       Impact factor: 6.011

Review 5.  Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension.

Authors:  Stevan P Tofovic; Edwin K Jackson
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

Review 6.  Sex Differences in Pulmonary Hypertension.

Authors:  Juan José Rodriguez-Arias; Ana García-Álvarez
Journal:  Front Aging       Date:  2021-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.